Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News BioVaxys Technology Corp. C.BIOV

Alternate Symbol(s):  BVAXF

BioVaxys Technology Corp. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on improving patient lives with novel immunotherapies based on the DPX immune-educating technology platform and its HapTenix neoantigen tumor cell construct platform, for treating cancers, infectious disease, antigen desensitization and other immunological fields. The Company's clinical... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (CSE:BIOV)

BIOVAXYS PARTNER SPAYVAC FOR WILDLIFE, INC., SCALES-UP VACCINE PRODUCTION CAPACITY

PR Newswire 2 days ago

BioVaxys and SpayVac expand vaccine production in Madison

Jocelyn Aspa 3 days ago

BioVaxys to Participate in the US Government Biomedical Advanced Research and Development Authority (BARDA) Rapid Response Partnership Vehicle (RRPV) Vaccine Development Consortium

PR Newswire November 5, 2024

BioVaxys' DPX outperforms traditional antigen delivery systems

Jocelyn Aspa October 31, 2024

BioVaxys' DPX Exhibits Superior Immune System Activation Compared to Aqueous and Emulsion-Based Antigen Delivery Systems

PR Newswire October 31, 2024

BioVaxys to Present at the Emerging Growth Conference on October 30th, 2024

PR Newswire October 28, 2024

BioVaxys Engages Dr. Rajkannan Rajagopalan as Vaccine Formulations Advisor

PR Newswire October 8, 2024

BIOVAXYS ANNOUNCES CLOSING OF FIFTH TRANCHE OF PRIVATE PLACEMENT

Canada NewsWire October 4, 2024

BIOVAXYS ANNOUNCES CLOSING OF FOURTH TRANCHE OF PRIVATE PLACEMENT

Canada NewsWire September 24, 2024
View More News ››

Opinion & Analysis (CSE:BIOV)

How BioVaxys' DPX platform creates anti-cancer immune response

Research October 8, 2024

Revolutionizing immunotherapies with groundbreaking DPX platform

Lyndsay Malchuk July 30, 2024

Unique Value-Added Antiviral Vaccine Technology Platform

Dave Jackson September 15, 2021
View More Opinion ››

Bullboard Posts (CSE:BIOV)

3/4 million shares traded today not including OTC US$

Sym-X Bid - Ask Last Chg %Ch Vol $Vol #Tr  &...
frankman - 9 hours ago

Level 2 bid ask

Ask 0.085 29,000 3 0.08 26,000 4 0.075 72...
frankman - 10 hours ago

Tech chart with accumulation distribution

frankman - 10 hours ago

Tech chart (accumulation stage) 30 day moving avg crosses 60

frankman - 10 hours ago

RE:Pfizer was once criticized for lack of vaccine development

What excites me is the many possible products that can be developed over time. This has a multiple earnings growth potential. I will be...
frankman - 11 hours ago

SpayVac

https://stockhouse.com/news/press-releases/2024/11/20/biovaxys-partner-spayvac-for-wildlife-inc-scales-up-vaccine-production-capacity
GoldCanuck28 - 11 hours ago
View more Bullboard ››

Western Metallica Resources Corp.

Western Metallica Resources Corp.

Western Metallica Resources Corp. is a Canada-based mineral exploration company with five mineral assets across Peru and ...
View More »